Atul brings a wealth of industry experience in immunology and other therapeutic areas and across the pharmaceutical value chain, including both strategy and execution.
During his tenure at Sanofi Genzyme, Dr. Deshpande delivered on roles with increasing responsibility from strategy to implementation. He was instrumental in establishing and executing global Dupixent launches in Atopic Dermatitis and Asthma, a blockbuster brand in the making. He also brings significant international experience, having developed the R&D strategy for the company’s Asia Pacific businesses, including Japan and China. Prior to Sanofi Genzyme, Dr. Deshpande served at many life science strategic consulting firms.
Dr. Deshpande holds a Ph.D. in Neurobiology and Behavior from University of California, Irvine and an MBA from Cranfield University in the UK.